HDFC Life Q4 FY26: Key numbers, solvency boost update

What stood out in HDFC Life’s Q4 FY26 print

HDFC Life Insurance’s Q4 FY26 results triggered a cautious market response after select headline metrics came in slightly below Street expectations. Annualised Premium Equivalent (APE) and Value of New Business (VNB) were marginally under consensus estimates, even as the VNB margin held at 24% for the quarter. Alongside the operating update, the company also disclosed a proposed capital infusion by parent HDFC Bank, aimed at strengthening the solvency position.

The mix of a near-term miss on volumes and profitability, and a clear capital planning step, shaped the immediate narrative for investors. The quarter also reflected product-mix shifts, higher expenses, and a modest dip in persistency at the 13-month level.

Q4 FY26 numbers vs expectations

For the quarter ended March 31, 2026, HDFC Life reported APE of ₹5,254 crore, below the ₹5,329 crore consensus estimate mentioned in the notes. VNB stood at ₹1,261 crore versus an estimate of ₹1,269 crore. The VNB margin was 24%, matching the expectation highlighted alongside the consensus.

Separately, the company reported net profit for the January to March quarter rising 4% year-on-year to ₹495.6 crore. Net premium income in Q4 FY26 increased 8.68% year-on-year to ₹25,829.43 crore.

Stock reaction and the short-term trading tape

HDFC Life’s stock fell 1.41% on April 16 to close at ₹631.55 after the Q4 FY26 shortfall versus estimates. The same note set this against a broader analyst consensus that still carries a ‘Strong Buy’ stance, with average 12-month price targets cited in a wide band from ₹832 to over ₹904.

The data set also points to near-term volatility around early April. One snapshot referenced the stock trading near ₹740, down from a 52-week high of ₹972, with a one-year return of -18%, and a 52-week low of ₹620. Another set of prices cited a move to ₹621.85 after a near-3% surge on April 13 and a dip to ₹604.15 by April 11, underscoring shifting sentiment around results and positioning.

Full-year FY26 profit and “underlying” growth

For the full fiscal year FY26, profit after tax was reported to have risen 6% to ₹1,910 crore. The same summary stated that underlying profit growth accelerated to 16% after adjusting for one-time impacts.

The quarter commentary also flagged that profitability was impacted by changes in goods and services tax (GST) and labour code regulations. These elements were cited as factors affecting the Q4 profitability profile.

Capital move: HDFC Bank to infuse ₹1,000 crore

A key FY26 event was the disclosure that HDFC Bank would infuse ₹1,000 crore through a preferential share issuance. This would raise the bank’s stake in HDFC Life to 50.5% from 50.2%.

The company said the infusion is expected to lift the solvency ratio to 186% from the current 177%. The solvency ratio had declined from 194% in Q4 FY25. The insurance regulator’s mandated solvency ratio is 150%.

HDFC Life executive director and CFO Niraj Shah told Business Standard: “Given that, it would take some time, and the over 45-46 per cent growth in protection business would require capital.” He also indicated the solvency ratio can improve to about 186%.

Protection business growth remains the operating highlight

Within operations, the retail protection segment continued to show strong traction, with growth of 43% for FY26 and 46% in the fourth quarter. This segment’s share of the retail business rose to 7.2%.

The note also cited assets under management (AUM) of ₹530,000 crore and stable persistency ratios as part of the foundation supporting business momentum. The protection mix improvement matters because protection typically demands capital but can improve the durability of earnings when managed well.

Product mix shifts across ULIPs, participating, and non-par

HDFC Life’s product mix moved meaningfully in FY26 versus FY25 in the disclosure provided. Unit-linked insurance plans (ULIPs) contributed 44% of the product mix, up from 39% in FY25. Participating products rose to 25% from 19%.

Non-participating products fell to 18% from 32%. Annuities were flat at 5%. Protection products increased to 7% from 5%.

These shifts help explain why the margin discussion stayed in focus: in Q4 FY26, the VNB margin was 24% versus 26.5% in Q4 FY25.

Costs, commissions, and persistency movements

HDFC Life reported expenses of ₹4,925.23 crore in Q4 FY26, up 14.51% year-on-year. Commission rose 7.89% year-on-year to ₹2,785.15 crore.

Persistency showed a mixed movement. The 13th-month persistency at the end of FY26 stood at 85%, down from 87% in FY25. The 61st-month persistency improved to 64% from 63%.

Valuation context: premium multiples and peers

The notes highlighted that HDFC Life carries a market capitalisation range of about ₹134,000 crore to ₹140,000 crore, while another snapshot put the market capitalisation at about ₹159,000 crore. On valuation, the trailing twelve-month P/E was cited in a band of about 68.97 to 73.06, compared with an insurance sector average P/E of about 21.71.

Peer SBI Life was cited with a market cap of about ₹200,000 crore and a P/E of about 81.87. The same summary stated HDFC Life has an 11.0% market share.

Industry backdrop and what investors may track next

The Indian life insurance market was projected in the notes to grow at an average annual rate of 6.9% between 2026 and 2030. Growth drivers cited included increasing financial literacy, supportive government policies, and rising demand for protection and retirement solutions.

On the regulatory and reporting side, the company said it has board approval to seek forbearance from the insurance regulator for transition to International Financial Reporting Standards.

Key data points at a glance

Market impact and why the quarter matters

The immediate market impact was a negative stock move following the APE and VNB miss versus expectations, even though the margin held at 24%. The capital action is material because the protection business has been growing at over 45-46% as referenced by the CFO, and that growth can require additional solvency support.

The solvency ratio trajectory also frames the discussion. Moving from 194% in Q4 FY25 to 177% currently, and a targeted 186% after the ₹1,000 crore infusion, gives investors a clearer picture of how the company is balancing growth and capital strength relative to the 150% regulatory threshold.

Conclusion

HDFC Life’s Q4 FY26 results were mixed: APE and VNB were slightly below estimates, VNB margin was steady at 24%, and profitability was influenced by GST and labour code changes. The planned ₹1,000 crore preferential infusion by HDFC Bank, taking solvency toward 186%, is likely to remain a central investor focus alongside protection growth and persistency trends. The next cues will come from how the product mix, costs, and capital position evolve as the company pursues growth in protection and other segments.